Vivus: into single digits Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vivus: into single digits

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: BDR who wrote (396)	4/28/1998 2:33:00 PM
From: Colby	Read Replies (2) of 1016

Dale, BigKNY, and other resident doctors, Did you catch the article in TIME Magazine? If not, its worth reading although it is as much a commentary on society as it is informative about Viagra. The one thing that really stood out was a subarticle (for lack of a better word) called "The Downside of Viagra". One out of 10 men in the clinical trials developed blinding headaches that grew more severe at higher doses. That seems like 1) a pretty high percentage and 2) pretty severe. I would stop taking medication way short of a "blinding headache". Would I be correct in assuming many other patients suffered headaches that stopped shy of being "blinding". Is the severity of this side effect normal in medications, or is this on the more extreme side? It seems to me, this headache combined with the other affects and inability of Viagra to mix with other drugs such as nitroglycerine leaves a lot of the ED market available for the likes of VVUS. Hope all is well, Colby

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next